Treatment patterns and outcomes in advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in China
Chinese patients with UAM GA/GEJA mainly received chemotherapy alone in 1 L/2 L and targeted therapy in 3 L. Median rwPFS was short in all lines, highlighting the need for more effective treatments.
Authors
- Grace Segall (ORCID: https://orcid.org/0000-0002-4942-7633)
- Chan Zhou (ORCID: https://orcid.org/0000-0002-0351-6235)
- Jinnan Li (ORCID: https://orcid.org/0009-0001-2600-956X)
- Wensheng Pan (ORCID: https://orcid.org/0000-0002-2347-1695)
- Nianhai Zhang
- Xianhe Xie (ORCID: https://orcid.org/0000-0002-4134-5887)
- Li Zhou (ORCID: https://orcid.org/0000-0003-3620-7073)
- Guangyu Wang (ORCID: https://orcid.org/0000-0003-4803-7200)
- Jingdong Zhang (ORCID: https://orcid.org/0000-0002-8370-9730)
- Qian Dong
- Jie Dong (ORCID: https://orcid.org/0000-0002-2526-8201)
- Yanqiao Zhang
Institutions
- Fujian Medical University (CN)
- Harbin Medical University (CN)
- Eli Lilly (United States) (US)
- Third Affiliated Hospital of Harbin Medical University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
- Zhejiang Provincial People's Hospital (CN)
- Lilly (China) (CN)
- Liaoning Cancer Hospital & Institute (CN)
- Hangzhou Medical College (CN)
Publication Details
- Journal
- Future Oncology
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1080/14796694.2025.2476930
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Eli Lilly and Company